Skip to content

VACCINOGEN INC

company.status.inactive

CIK 1453001fmd_0CXQX4NVW25YMSVT2XE8G1J2TXManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Sep 30, 2015, 13 periods

Latest annual · FY2014

Millions
Total revenues
0
Operating income
(15)
Net income
(9)
Free cash flow
(12)

Latest quarter · Q3 FY2015

Millions
Total revenues
0
Operating income
(8)
Net income
(8)
Free cash flow
(1)
Open Financials

VACCINOGEN INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2014FY2013ChangeSource
Revenue$0$010-K 2015-04-15 · proof
Operating income-$14.8 million-$19.4 million10-K 2015-04-15 · proof
Net income-$8.5 million-$24.6 million10-K 2015-04-15 · proof
Cash from operating activities-$11.6 million-$3.7 million10-K 2015-04-15 · proof
Free cash flow-$11.9 million-$3.8 million10-K 2015-04-15 · proof
Total assets$71.1 million$63.3 million+12.4%10-K 2015-04-15 · proof
Total liabilities$18.2 million$22.6 million-19.6%10-K 2015-04-15 · proof
Cash and cash equivalents$3 million$73,096+4,060.2%10-K 2015-04-15 · proof
What was VACCINOGEN INC's revenue in fiscal 2014?
VACCINOGEN INC reported revenue of $0 for fiscal 2014 (the year ended Dec 31, 2014), against $0 the year before. Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What was VACCINOGEN INC's operating income in fiscal 2014?
VACCINOGEN INC reported operating income of -$14.8 million for fiscal 2014 (the year ended Dec 31, 2014), against -$19.4 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What was VACCINOGEN INC's net income in fiscal 2014?
VACCINOGEN INC reported net income of -$8.5 million for fiscal 2014 (the year ended Dec 31, 2014), against -$24.6 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What was VACCINOGEN INC's cash from operating activities in fiscal 2014?
VACCINOGEN INC reported cash from operating activities of -$11.6 million for fiscal 2014 (the year ended Dec 31, 2014), against -$3.7 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What was VACCINOGEN INC's free cash flow in fiscal 2014?
VACCINOGEN INC reported free cash flow of -$11.9 million for fiscal 2014 (the year ended Dec 31, 2014), against -$3.8 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What are VACCINOGEN INC's total assets?
As of Dec 31, 2014, VACCINOGEN INC reported total assets of $71.1 million, against $63.3 million a year earlier (+12.4%). Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What are VACCINOGEN INC's total liabilities?
As of Dec 31, 2014, VACCINOGEN INC reported total liabilities of $18.2 million, against $22.6 million a year earlier (-19.6%). Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What are VACCINOGEN INC's cash and cash equivalents?
As of Dec 31, 2014, VACCINOGEN INC reported cash and cash equivalents of $3 million, against $73,096 a year earlier (+4,060.2%). Source: the 10-K filed with the SEC on Apr 15, 2015. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1453001&period_type=annual&limit=5"

Information only, not investment advice.